Novo Nordisk A/S News - September 10, 2026

Novo Nordisk wins China approval for Wegovy, first GLP-1 for liver disease

Novo Nordisk announced Thursday that China’s National Medical Products Administration approved Wegovy for a new medical use. The drug will treat metabolic...